Literature DB >> 15826860

Axonal potassium conductance and glycemic control in human diabetic nerves.

Sonoko Misawa1, Satoshi Kuwabara, Kazuaki Kanai, Noriko Tamura, Akiyuki Hiraga, Miho Nakata, Kazue Ogawara, Takamichi Hattori.   

Abstract

OBJECTIVE: To investigate the effects of hyperglycemia on axonal excitability and potassium conductance in human diabetic nerves.
METHODS: Threshold tracking was used to measure excitability indices, which depend on potassium channels (supernormality, late subnormality, threshold electrotonus, and a current/threshold relationship) in median motor axons of 96 diabetic patients. The effects of hyperglycemia on these indices were analyzed.
RESULTS: Among diabetic patients, higher serum hemoglobin A1c (HbA1c) levels were significantly associated with greater supernormality (P = 0.04) and smaller late subnormality (P = 0.02), suggestive of reduced nodal/paranodal potassium currents under hyperglycemia. Threshold electrotonus and current/threshold relationships did not correlate with HbA1c levels, but partly related with nerve conduction slowing.
CONCLUSIONS: Hyperglycemia could reduce nodal potassium conductances, possibly due to reduced membranous potassium gradient or suppression of potassium channels. In contrast, internodal potassium conductances may be determined by both metabolic factors and structural changes such as exposure of internodal channels by demyelination. SIGNIFICANCE: Measurements of the excitability indices could provide new insights into nodal and internodal axonal membrane properties in human diabetic neuropathy, whereas multiple factors can affect especially internodal properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15826860     DOI: 10.1016/j.clinph.2004.12.019

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  10 in total

Review 1.  Neuropathic pain in diabetes--evidence for a central mechanism.

Authors:  Tanya Z Fischer; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

2.  Temporal course of streptozotocin-induced diabetic polyneuropathy in rats.

Authors:  Yee-Fun Lee; Chou-Ching K Lin; Gin-Shin Chen
Journal:  Neurol Sci       Date:  2014-06-13       Impact factor: 3.307

Review 3.  Recent developments in the assessment of efficacy in clinical trials of diabetic neuropathy.

Authors:  Moaz Mojaddidi; Cristian Quattrini; Mitra Tavakoli; Rayaz A Malik
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

4.  Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study.

Authors:  Andreas C Themistocleous; Alexander G Kristensen; Roma Sola; Sandra S Gylfadottir; Kristine Bennedsgaard; Mustapha Itani; Thomas Krøigård; Lise Ventzel; Søren H Sindrup; Troels S Jensen; Hugh Bostock; Jordi Serra; Nanna B Finnerup; Hatice Tankisi; David L H Bennett
Journal:  Ann Neurol       Date:  2022-03-07       Impact factor: 11.274

5.  Plasticity of inwardly rectifying conductances following a corticospinal lesion in human subjects.

Authors:  Stacey K Jankelowitz; James Howells; David Burke
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

6.  Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy.

Authors:  Angelika Bierhaus; Thomas Fleming; Stoyan Stoyanov; Andreas Leffler; Alexandru Babes; Cristian Neacsu; Susanne K Sauer; Mirjam Eberhardt; Martina Schnölzer; Felix Lasitschka; Felix Lasischka; Winfried L Neuhuber; Tatjana I Kichko; Ilze Konrade; Ralf Elvert; Walter Mier; Valdis Pirags; Ivan K Lukic; Michael Morcos; Thomas Dehmer; Naila Rabbani; Paul J Thornalley; Diane Edelstein; Carla Nau; Josephine Forbes; Per M Humpert; Markus Schwaninger; Dan Ziegler; David M Stern; Mark E Cooper; Uwe Haberkorn; Michael Brownlee; Peter W Reeh; Peter P Nawroth
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

7.  Peripheral nerve axon involvement in myotonic dystrophy type 1, measured using the automated nerve excitability test.

Authors:  Jong Seok Bae; Sang Gin Kim; Jeong Cheol Lim; Eun Joo Chung; Oeung Kyu Kim
Journal:  J Clin Neurol       Date:  2011-06-28       Impact factor: 3.077

8.  Early sensory neurophysiological changes in prediabetes.

Authors:  Yi-Chen Lin; Cindy Shin-Yi Lin; Tsui-San Chang; Jing-Er Lee; Jowy Tani; Hung-Ju Chen; Jia-Ying Sung
Journal:  J Diabetes Investig       Date:  2019-11-09       Impact factor: 4.232

9.  Effects of axonal ion channel dysfunction on quality of life in type 2 diabetes.

Authors:  Natalie C G Kwai; Ria Arnold; Chathupa Wickremaarachchi; Cindy S-Y Lin; Ann M Poynten; Matthew C Kiernan; Arun V Krishnan
Journal:  Diabetes Care       Date:  2013-02-12       Impact factor: 19.112

10.  Vasomodulation of peripheral blood flow by focused ultrasound potentiates improvement of diabetic neuropathy.

Authors:  Joo-Shin Tan; Chou-Ching Lin; Gin-Shin Chen
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.